Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T N Chase

Showing results (161-170 of 397) with videos related to

Pageof 40
Sort By:
Endocrinology|July 1, 1987
Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptideK Tanimoto, C A Tamminga, T N Chase, et al.
Lancet (London, England)|August 14, 1971
Inhibition of drug metabolism by levodopa in combination with a dopa-decarboxylase inhibitorE S Vesell, L Ng, G T Passananti, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1990
Selective deficits in Alzheimer and parkinsonian dementia: visuospatial functionE Mohr, I Litvan, J Williams, et al.
Neuroscience Letters|October 1, 1993
GABAA and GABAB receptors differentially regulate striatal acetylcholine release in vivoJ J Anderson, S Kuo, T N Chase, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1994
Dopamine D1 receptor-stimulated release of acetylcholine in rat striatum is mediated indirectly by activation of striatal neurokinin1 receptorsJ J Anderson, S Kuo, T N Chase, et al.
Peptides|January 1, 1983
Tolerance to the anti-avoidance properties of cholecystokinin-octapeptideS L Cohen, M Knight, C A Tamminga, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1978
Stimulation of prolactin and growth hormone secretion by muscimol, a gamma-aminobutyric acid agonistC A Tamminga, A Neophytides, T N Chase, et al.
Experimental Neurology|April 1, 1991
Striatal D1 dopamine receptor morphochemistry following continuous or intermittent L-dopa replacement therapyM A Ariano, T M Engber, Z Susel, et al.
Annals of Neurology|January 1, 1990
Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's diseaseM M Mouradian, I J Heuser, F Baronti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1991
Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's diseaseI Litvan, E Mohr, J Williams, et al.
Pageof 40

Showing results (161-170 of 397) with videos related to

Sort By:
Pageof 40
Endocrinology|July 1, 1987
Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptideK Tanimoto, C A Tamminga, T N Chase, et al.
Lancet (London, England)|August 14, 1971
Inhibition of drug metabolism by levodopa in combination with a dopa-decarboxylase inhibitorE S Vesell, L Ng, G T Passananti, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1990
Selective deficits in Alzheimer and parkinsonian dementia: visuospatial functionE Mohr, I Litvan, J Williams, et al.
Neuroscience Letters|October 1, 1993
GABAA and GABAB receptors differentially regulate striatal acetylcholine release in vivoJ J Anderson, S Kuo, T N Chase, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1994
Dopamine D1 receptor-stimulated release of acetylcholine in rat striatum is mediated indirectly by activation of striatal neurokinin1 receptorsJ J Anderson, S Kuo, T N Chase, et al.
Peptides|January 1, 1983
Tolerance to the anti-avoidance properties of cholecystokinin-octapeptideS L Cohen, M Knight, C A Tamminga, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1978
Stimulation of prolactin and growth hormone secretion by muscimol, a gamma-aminobutyric acid agonistC A Tamminga, A Neophytides, T N Chase, et al.
Experimental Neurology|April 1, 1991
Striatal D1 dopamine receptor morphochemistry following continuous or intermittent L-dopa replacement therapyM A Ariano, T M Engber, Z Susel, et al.
Annals of Neurology|January 1, 1990
Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's diseaseM M Mouradian, I J Heuser, F Baronti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1991
Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's diseaseI Litvan, E Mohr, J Williams, et al.
Pageof 40